Second, it has been demonstrated that N-myc amplification had a major prognostic value in localised NB, including in infants; indeed, although rare in that subset of patients, N-myc amplification has a strong negative influence on outcome (Rubie et al, 1997). This evidence concerns the gene MYCN and neuroblastoma.